CFML
REGN icon

COMPASS FINANCIAL MANAGEMENT LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5K Buy
+65
New +$44.2K ﹤0.01% 726

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's REGN Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 65 shares worth $40.5K. The stake represents ﹤0.01% of the portfolio and ranks #726 among its holdings.

1,046 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 65 shares of Regeneron Pharmaceuticals worth $40.5K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #726 holding.
  • 1,046 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.